Important Information for the Restart of Human Subjects Research

Plan for the Return of Research with Human Participants at Johns Hopkins

View July 31 Announcement from the Vice Dean for Clinical Investigation

 

Phase 1 Guidance on the Resumption of On-Campus Research Activities at Johns Hopkins University

The initial Phase of Human Subjects Research Restart aligned with Phase 1 of the University plan will prioritize therapeutic trials/interventional studies with potential for direct benefit to study participants conducted in Johns Hopkins clinical facilities. Research resumption involving interactions with human subjects are presented in depth in Part Five of the JHU Return to Research Guidance.  Please see:

https://hub.jhu.edu/assets/uploads/sites/2/2020/05/Research_Restart_Guidelines_Phase_1.pdf

 

Process for Preparing Plans for Johns Hopkins University School of Medicine Principal Investigators who Supervise Staff Involved in Human Participant Research

This form is for principal investigators to complete in order to provide plans for a safe work space for clinical research staff.

Instructions and FAQ for the Human Participant Research Staff Form

Complete Online Survey Form

View/Print Survey Form

 

Human Subjects Research Protocol Restart Committee (HSRPRC)

A Human Subjects Research Protocol Restart Application is required as the first step of the process to receive permission to restart (or start) in-person interactions with research participants on a specific protocol outside of the Sidney Kimmel Comprehensive Cancer Center or Johns Hopkins All Children’s Hospital (these two units have their own designated subcommittees/process to review restart applications). The Submission of this application (one required per protocol) will put you in a queue to have your request reviewed by the Human Subjects Research Protocol Restart Committee (the HSRPRC). The HSRPRC must approve your study to move forward to the IRB for permission to restart clinical research.

More information can be found on the IRB website: https://www.hopkinsmedicine.org/institutional_review_board/news/covid19_information.html/index.html